BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230330T100000
DTEND;TZID=UTC:20230330T110000
DTSTAMP:20260404T145840
CREATED:20230329T123208Z
LAST-MODIFIED:20241024T182851Z
UID:10000627-1680170400-1680174000@staging.digitalinsights.supremeclients.com
SUMMARY:Accéder rapidement à une connaissance exhaustive pour l’interprétation des variants somatiques avec HSMD
DESCRIPTION:L’interprétation et la classification des variants somatiques demeurent un challenge alors que le nombre de gènes testés continue d’augmenter faisant apparaitre de nouvelles altérations. Ces nouveaux variants dont l’impact clinique est encore inconnu nécessitent une recherche d’information croisée à partir de nombreuses sources. Déterminer la classification d’un variant peut donc s’avérer longue et fastidieuse. La base de variants somatiques HSMD est une ressource en ligne qui vous permet rapidement et en toute confiance de classer vos nouveaux variants. En effet\, HSMD contient plus de 300 000 cas en oncologie clinique et plus de 1\,5 millions de mutations et leurs données associées\, manuellement capturées et intégrées dans la base de connaissance QIAGEN. Le profil mutationnel de gènes d’intérêt\, les gènes fréquemment mutés dans une pathologie donnée\, l’actionnabilité d’un gène ou encore les essais cliniques pour un cancer ou un traitement spécifique sont des requêtes que les utilisateurs d’HSMD peuvent effectuer simplement. Vous découvrirez lors de ce webinaire comment utiliser HSMD pour votre routine clinique ou dans un cadre de recherche translationnelle.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/acceder-rapidement-a-une-connaissance-exhaustive-pour-linterpretation-des-variants-somatiques-avec-hsmd/
CATEGORIES:Clinical,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230323T130000
DTEND;TZID=America/New_York:20230323T143000
DTSTAMP:20260404T145840
CREATED:20230307T163759Z
LAST-MODIFIED:20241024T182839Z
UID:10000607-1679576400-1679581800@staging.digitalinsights.supremeclients.com
SUMMARY:Multi-omics (metabolomics\, proteomics\, transcriptomics) analysis using QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:This 90-minute training session is about how QIAGEN Ingenuity Pathway Analysis (IPA) allows visualization of molecular intricacy and variations at multiple levels such as transcriptome\, proteome\, and metabolome. Through a series of brief technical vignettes\, it is demonstrated how to: \n· Generate associations among molecular signatures obtained via integrating multi-omics data \n· Extract mechanisms from multi-omics data for precision medicine \n· Disease stratification based on multi-omics profiles \n· Map disease networks among targets and indications \n  \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/multi-omics-metabolomics-proteomics-transcriptomics-analysis-using-qiagen-ingenuity-pathway-analysis-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230323T110000
DTEND;TZID=America/New_York:20230323T120000
DTSTAMP:20260404T145840
CREATED:20230309T161946Z
LAST-MODIFIED:20241024T182845Z
UID:10000614-1679569200-1679572800@staging.digitalinsights.supremeclients.com
SUMMARY:How to simplify somatic NGS analysis & reduce literature review time by 90% with HSMD
DESCRIPTION:Across clinical oncology applications\, from molecular testing to cancer research\, the ability to identify potentially actionable genomic and genetic alterations to exploit the molecular vulnerabilities of cancer is a burgeoning field. Due to the sporadic nature of somatic cancers and the expansion of next-generation sequencing\, the number of variants detected through tumor testing is growing exponentially\, presenting a challenge to clinical cancer genetics professionals working to confidently identify meaningful mutations that could influence decision-making at point-of-care.\n\nJoin Chelsea Alexander\, a certified genetic counselor\, and Aarthi Goverdhan\, our lead oncology application development scientist\, for a live webinar on Thursday\, March 23rd at 11 AM EST to discover a new database that can streamline your somatic NGS analysis and significantly reduce your literature review time—by up to 90%!\n\nIn this webinar\, we will introduce you to the Human Somatic Mutation Database (HSMD)—a new somatic database developed by QIAGEN that contains extensive genomic content relevant to solid tumors and hematological malignancies. Available as a web-based application\, this expert-curated resource contains data from over 419\,000 real-world clinical oncology cases combined with insights from the QIAGEN Knowledge Base\, providing clinically observed variant frequencies across diseases\, and diving deep into gene-level\, alteration-level and disease-level information. Users can easily search and explore mutational characteristics across genes\, synthesize key findings from drug labels and professional guidelines\, explore clinical trials\, and receive detailed annotations for each observed variant. In addition\, users can interrogate a bibliography of over 170\,000 PubMed articles and access detailed alteration-specific summaries written by PhD scientists.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-simplify-somatic-ngs-analysis-reduce-literature-review-time-by-90-with-hsmd/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/png:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/EmailHeader_LabrootsWebinarHSMD_0223_16x9_round.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230322T120000
DTEND;TZID=UTC:20230322T130000
DTSTAMP:20260404T145840
CREATED:20230310T075449Z
LAST-MODIFIED:20241024T182845Z
UID:10000615-1679486400-1679490000@staging.digitalinsights.supremeclients.com
SUMMARY:Lowering NGS analysis cost at lightspeed
DESCRIPTION:Advances in next-generation sequencing (NGS) technologies over the years have significantly decreased the cost of whole genome (WGS) and whole exome (WES) applications\, such that they are considered the standard of care within multiple healthcare organizations. Arguably\, the most significant NGS challenges lie within data analysis and interpretation. Various parameters such as sensitivity\, specificity\, cost and speed are critical for secondary analysis\, while accurate\, comprehensive and up-to-date content is required for reliable interpretation. These aspects are crucial\, especially where rapid turnaround times are critical for improved health outcomes. There is no better example than the implementation of WES and WGS in the neonatal and pediatric intensive care units (NICU/PICU). \nJoin this webinar to learn about QIAGEN CLC LightSpeed\, a secondary analysis software that dramatically reduces the cost and time it takes to analyze WES and WGS data and generate actionable insights. \nKey learning objectives \n\nLearn how to process FASTQ files to obtain quality variant calls in minutes\nDiscover how LightSpeed can be used on existing laptops\, desktops\, servers\, HPC or in the cloud\nLearn how LightSpeed will reduce your cost without sacrificing quality\nExplore how LightSpeed enables the fastest WES and WGS workflow from FASTQ to report\n\nWho should attend? \nBioinformaticians\, Geneticists\, Lab managers\, NGS technicians\, researchers\, and biologists
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/lowering-ngs-analysis-cost-at-lightspeed/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230316T130000
DTEND;TZID=America/New_York:20230316T143000
DTSTAMP:20260404T145840
CREATED:20230307T175844Z
LAST-MODIFIED:20241024T182844Z
UID:10000612-1678971600-1678977000@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deeper dive: Generating novel discoveries in IPA - even when you don’t have data
DESCRIPTION:Take a deeper dive into the discovery capabilities of QIAGEN IPA. In this training\, you will learn how to:\n• Leverage the IPA knowledge base to generate hypotheses regarding novel biological mechanisms\, discover biomarkers and targets as well as design experiments.\n• Generate interactive networks using genes\, chemicals and diseases of interest\n• Search and interpret pathway analyses generated from public data (GEO\, SRA etc.)\n• Study gene or biomarker expression across different tissues\, diseases\, cell types and more from public sources\n• Correlate expression of genes across your biological condition of interest\n• Generate survival curves for cohorts generated based on expression or mutation status of a gene \nSpecific IPA analyses to be featured include:\n• Network construction (with and without data) • Activity Plot • Pattern Search • QIAGEN OmicSoft Land Explorer • Among others
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deeper-dive-generating-novel-discoveries-in-ipa-even-when-you-dont-have-data/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230314T130000
DTEND;TZID=UTC:20230314T143000
DTSTAMP:20260404T145840
CREATED:20230307T172637Z
LAST-MODIFIED:20241024T182843Z
UID:10000609-1678798800-1678804200@staging.digitalinsights.supremeclients.com
SUMMARY:Biomarker discovery and disease pathology investigation using QIAGEN OmicSoft and Ingenuity Pathway Analysis
DESCRIPTION:In this training\, attendees will learn how to harness curated ‘omics datasets in OmicSoft DiseaseLand and curated research findings in IPA to discover new potential biomarkers. Using a neurological disorder as a case study\, we will:\n• Search public RNA-Seq datasets for tissue- and disease-specific differential expression in brain\n• Identify genes whose expression correlates with our factor within a sample group\n• Prioritize candidate biomarkers by disease vs. normal expression\n• Simulate biomarker activity changes to determine potential mechanisms of action\nInvestigation of inflammatory\, infectious\, oncological\, and other disorders can also be done using similar approach and will be highlighted during this training. \n  \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/biomarker-discovery-and-disease-pathology-investigation-using-qiagen-omicsoft-and-ingenuity-pathway-analysis-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230312T000000
DTEND;TZID=UTC:20230312T235900
DTSTAMP:20260404T145840
CREATED:20230301T075831Z
LAST-MODIFIED:20241024T182832Z
UID:10000596-1678579200-1678665540@staging.digitalinsights.supremeclients.com
SUMMARY:Authenticated and reproducible cell line 'omics data
DESCRIPTION:Have you ever tried to access the genomic profiles of cell lines before using them in your preclinical experiments just to come up empty-handed? Maybe you’ve scoured public databases for gene expression information on your cell line to find the reported genomic profile doesn't match the cell line data you recently purchased? \nWe understand that knowing the genomic identity of your cell lines is fundamental to the success of your preclinical experiments. Unfortunately\, most publicly available sources have little or no cell line' omics data\, leaving you to fend for yourself. \nThat's why we've teamed up with ATCC\, the market leader in global biological materials and authenticated cell lines\, to deliver you manually curated cell line ‘omics data from the most popular cell lines offered by ATCC. We've collected this data into ATCC Cell Line Land\, our continually growing database of cell line 'omics data from both common and novel human and mouse cell lines\, primary tissues and cells from ATCC. ATCC Cell Line Land gives you access to standardized\, authenticated and reproducible cell line 'omics data characterizations which can be traced back to physical lots of cells in ATCC's biorepository. \nAttend our joint webinar with ATCC to learn about and explore ATCC Cell Line Land\, including: \n\nThe key limitations of public cell line data that drove its development\nHow we curate our data in the QIAGEN OmicSoft Lands framework\nWhy you can depend on the provenance of the data\nThe different types of 'omics data and metadata available\nHow it empowers you to plan and design your preclinical experiments more precisely\nHow to identify specific cell lines that express your gene of interest and those that don't\nHow to validate specific mutations from the literature\n\nWho should attend? Biologists\, preclinical researchers\, bioinformaticians\, data scientists \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/authenticated-and-reproducible-cell-line-omics-data/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1108_8_QDI_CLC_Challenger_Or54963_16x9_56810_Large-1200px-2.jpg
ORGANIZER;CN="Test organizer 1":MAILTO:test@test.test
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230309T130000
DTEND;TZID=America/New_York:20230309T143000
DTSTAMP:20260404T145840
CREATED:20230307T174810Z
LAST-MODIFIED:20241024T182843Z
UID:10000610-1678366800-1678372200@staging.digitalinsights.supremeclients.com
SUMMARY:Isolate Typing\, Strain Identification and Anti-Microbial Resistance Analyses Using QIAGEN CLC Genomics Workbench
DESCRIPTION:QIAGEN CLC Genomics Workbench provides tools and workflows for a broad range of bioinformatics applications\, including microbiome analysis\, isolate characterization through SNP and K-mer trees using NGS data\, and antimicrobial resistance characterization. CLC Genomics Workbench is widely used for analyses of bacterial\, viral and eukaryotic (fungal) genomes and metagenomes. \nTopics covered in this webinar include: \nI. Overview of different tools within MGM application and research areas supported\nII. Focused review of isolate typing and characterization\na. Importing data\nb. Utilization of metadata\nc. Downloading and managing references\ni. Database of Isolates/ Resistances/ MLST\nd. Walk through of Type a Known Species workflow\ni. Review details for each Isolate\ne. Creating SNP profiles to specific reference\nf. Generate a SNP tree for isolate comparison\ng. Export tabular and high-quality graphical outputs in wide range of file formats \n  \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/isolate-typing-strain-identification-and-anti-microbial-resistance-analyses-using-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230307T130000
DTEND;TZID=America/New_York:20230307T143000
DTSTAMP:20260404T145840
CREATED:20230307T175508Z
LAST-MODIFIED:20241024T182843Z
UID:10000611-1678194000-1678199400@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Join us for a 90-minute training session for new users of QIAGEN IPA. \nUsers will learn how to:\n• Upload their dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, timepoints\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation \n 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ingenuity-pathway-analysis-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230307T110000
DTEND;TZID=America/New_York:20230307T120000
DTSTAMP:20260404T145840
CREATED:20230307T171957Z
LAST-MODIFIED:20241024T182840Z
UID:10000608-1678186800-1678190400@staging.digitalinsights.supremeclients.com
SUMMARY:Comprehensive Molecular Tumor Analysis with Alacris Theranostics
DESCRIPTION:Join Dr. Marie-Laure Yaspo\, Co-Founder and Chief Scientific Officer of Alacris Theranostics\, as she discusses the development\, application\, and analysis of the Comprehensive Molecular Tumor Analysis (CMTA) test for cancer patients. \n\nPrecision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choices. However\, deeper molecular insights are needed to improve personalized treatment decisions. Integrating gene expression analysis in personalized oncology provides an additional level of insight. These analyses include evaluating expressed mutations and drug targets\, novel gene fusions\, clinically relevant signatures\, and the tumor immune microenvironment (TME). \nAlacris Theranostics developed the Comprehensive Molecular Tumor Analysis (CMTA)\, a NGS-based tumor diagnostic test. The test integrates whole exome and transcriptomic sequencing (WES and RNAseq). The test deploys as an end-to-end accredited diagnostic platform from tumor sample uptake (FFPE or frozen) to personalized clinical interpretation reports.  CMTA is a tumor-agnostic test that displays a unique molecular view of each sample. CMTA is a useful approach for refractory cancers with complex patterns or tumors of unknown origin. \nIn this webinar\, attendees will: \n\nLearn about the strategy implemented in Alacris’ bioinformatics pipeline to identify cancer-relevant somatic events\nLearn how Alacris uses QCI Interpret for Oncology to annotate variants and identify potential therapies\nBe eligible for a complimentary QCI Interpret demo and sample report\n\n 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/comprehensive-molecular-tumor-analysis-with-alacris-theranostics-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/png:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/230307_SoMe_BAN_QCI_Webinar_Alacris_16x9.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230302T130000
DTEND;TZID=America/New_York:20230302T143000
DTSTAMP:20260404T145840
CREATED:20230301T090150Z
LAST-MODIFIED:20241024T182838Z
UID:10000606-1677762000-1677767400@staging.digitalinsights.supremeclients.com
SUMMARY:Drug treatment\, toxicology and target safety assessment using QIAGEN IPA and OmicSoft
DESCRIPTION:In this 90-minute training\, you’ll learn how to do drug treatment\, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands.\nUsing public data from GTEx (normal tissue)\, GEO\, cancer collections and more\, you’ll learn how to use Omicsoft Lands to:\n• Investigate a drug target or biomarker expression across different normal tissues\, disease conditions\, treatments and more\n• Correlate expression of two or more genes\n• Identify a list of genes or biomarkers specific to treatment\, disease\, normal tissue\, cell type and more \nUsing findings from peer-reviewed publications and other sources\, attendees we’ll explore with you how to use QIAGEN IPA to:\n• Study the impact of targeting a gene/protein on different toxicological and biological functions\n• Derive tox findings for a gene of interest from QIAGEN IPA’s knowledgebase\n• Identify and study toxicity-related pathways\, regulators and functions for an internal dataset or a public dataset\n• Compare different drug treatments\, other conditions or multi-omics data for novel discoveries \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/drug-treatment-toxicology-and-target-safety-assessment-using-qiagen-ipa-and-omicsoft-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230222T130000
DTEND;TZID=UTC:20230222T130000
DTSTAMP:20260404T145840
CREATED:20230301T080935Z
LAST-MODIFIED:20241024T182833Z
UID:10000597-1677070800-1677070800@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deeper dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:In this 90-minute training session\, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways\, diseases\, biological functions\, tissues and cell types. \nTopics covered:\n- How to analyze miRNA-seq datasets alone\, or both miRNA and corresponding mRNA datasets together\n- How to use QIAGEN IPA without a dataset\, using miRNA IDs\n- Introduction to databases and curated content specific to miRNA\n- How to effectively apply various filters and functionalities to identify biomarkers\, key targets and novel biological mechanisms \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deeper-dive-mirna-investigation-using-qiagen-ingenuity-pathway-analysis-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230217T140000
DTEND;TZID=UTC:20230217T150000
DTSTAMP:20260404T145840
CREATED:20230301T081254Z
LAST-MODIFIED:20241024T182834Z
UID:10000598-1676642400-1676646000@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN IPA deep-dive training\, Europe and Middle East
DESCRIPTION:Join us for a 90-minute training session to learn more about the advanced features of QIAGEN IPA \nUsers will learn how to:\n•Search across over 120\,000 analysed public datasets to find analyses of biological interest\n•Find experimental conditions that match a user’s data\n•Understand how to compare biological signatures and expression patterns of biomarkers across published studies
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ipa-deep-dive-training-europe-and-middle-east/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221215T080000
DTEND;TZID=UTC:20221221T170000
DTSTAMP:20260404T145840
CREATED:20230301T082124Z
LAST-MODIFIED:20241024T182834Z
UID:10000599-1671091200-1671642000@staging.digitalinsights.supremeclients.com
SUMMARY:American Society of Human Genetics (ASHG)
DESCRIPTION:Forge lasting collaborations\, present emerging science\, and explore new tools & technologies that will transform your science and accelerate your career growth only at ASHG’s Annual Meeting.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/american-society-of-human-genetics-ashg/
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9051_LS_Labo2019_SoMe_Email_881627278_16x9_46408_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221110T080000
DTEND;TZID=UTC:20221125T170000
DTSTAMP:20260404T145840
CREATED:20230301T082750Z
LAST-MODIFIED:20241024T182834Z
UID:10000600-1668067200-1669395600@staging.digitalinsights.supremeclients.com
SUMMARY:3rd Annual Real-World Data\, Life Sciences Analytics and Market Access
DESCRIPTION:While the 2nd annual Congress had discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation\, the 3rd Annual will focus on how the insights derived from real world data\, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators\, doctors\, and payers.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/3rd-annual-real-world-data-life-sciences-analytics-and-market-access/
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1250_7_QDI_QCI_GenQA_article_16x9-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221104
DTEND;VALUE=DATE:20221105
DTSTAMP:20260404T145840
CREATED:20230301T083632Z
LAST-MODIFIED:20241024T182835Z
UID:10000601-1667520000-1667606399@staging.digitalinsights.supremeclients.com
SUMMARY:ACGS Annual Meeting 2021
DESCRIPTION:The ACGS Organising Committee is looking forward to delivering an exciting programme to showcase the ACGS laboratory diagnostic community. The ACGS encourage participation by trainees and early career investigators from the UK and Ireland.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/acgs-annual-meeting-2021/
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1193_3_QDI_QDI_generic_4398_ATCC.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220529T010000
DTEND;TZID=UTC:20220529T143000
DTSTAMP:20260404T145840
CREATED:20230301T084646Z
LAST-MODIFIED:20241024T182835Z
UID:10000602-1653786000-1653834600@staging.digitalinsights.supremeclients.com
SUMMARY:Drug treatment\, toxicology and target safety assessment using QIAGEN IPA and OmicSoft
DESCRIPTION:In this 90-minute training\, you’ll learn how to do drug treatment\, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands.\nUsing public data from GTEx (normal tissue)\, GEO\, cancer collections and more\, you’ll learn how to use Omicsoft Lands to:\n• Investigate a drug target or biomarker expression across different normal tissues\, disease conditions\, treatments and more\n• Correlate expression of two or more genes\n• Identify a list of genes or biomarkers specific to treatment\, disease\, normal tissue\, cell type and more \nUsing findings from peer-reviewed publications and other sources\, attendees we’ll explore with you how to use QIAGEN IPA to:\n• Study the impact of targeting a gene/protein on different toxicological and biological functions\n• Derive tox findings for a gene of interest from QIAGEN IPA’s knowledgebase\n• Identify and study toxicity-related pathways\, regulators and functions for an internal dataset or a public dataset\n• Compare different drug treatments\, other conditions or multi-omics data for novel discoveries \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/drug-treatment-toxicology-and-target-safety-assessment-using-qiagen-ipa-and-omicsoft/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1109_2_QDI_CLC_Challenger_Or55151_16x9_56855_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220423T020000
DTEND;TZID=UTC:20220423T150000
DTSTAMP:20260404T145840
CREATED:20230301T085144Z
LAST-MODIFIED:20241024T182835Z
UID:10000603-1650679200-1650726000@staging.digitalinsights.supremeclients.com
SUMMARY:New user training Europe and Middle East: Large dataset analysis and knowledge base queries using QIAGEN IPA
DESCRIPTION:Join us for a 60-minute training session for new users of QIAGEN IPA. \nUsers will learn how to:\n• Upload their dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, timepoints\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-europe-and-middle-east-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ipa/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220330T010000
DTEND;TZID=UTC:20220330T140000
DTSTAMP:20260404T145840
CREATED:20230301T085402Z
LAST-MODIFIED:20241024T182837Z
UID:10000604-1648602000-1648648800@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN CLC Main Workbench training
DESCRIPTION:Introduction to QIAGEN CLC Main Workbench\n• Alignment and tree construction\n• Sanger sequencing analysis\n• Cloning and primer design\n• Other molecular biology tools \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-clc-main-workbench-training/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20201113T080000
DTEND;TZID=UTC:20201113T170000
DTSTAMP:20260404T145840
CREATED:20230301T090036Z
LAST-MODIFIED:20241024T182838Z
UID:10000605-1605254400-1605286800@staging.digitalinsights.supremeclients.com
SUMMARY:BioData World Congress 2020
DESCRIPTION:Join QIAGEN Digital Insights Nov. 9–12 for the BioData World Congress 2020 online event\, the world's leading congress for big data and artificial intelligence (AI) in life science and healthcare. Explore the QIAGEN Digital Insights virtual booth to discover how our bioinformatics solutions for 'omics data analysis\, management and interpretation\, as well as tools involving artificial intelligence and machine learning\, can transform your research and help you drive discoveries by providing greater efficiency and insights. Join the talk by our expert Jeff Green on Nov. 11 at 9:20 a.m. to learn about Coronavirus Network Explorer\, our new web portal with 70 networks depicting how SARS-CoV-2 might affect host cells and tissues. Set up a 1:1 meeting with our experts to explore how QIAGEN Digital Insights can help advance your research.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/biodata-world-congress-2020/
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1203_4_QDI_QCI_InterpretOne_Gi1321701060_Large-1200px_62398.jpg
END:VEVENT
END:VCALENDAR